Common Technical Approaches and Key Operational Points for Pathogen Nucleic Acid Detection

Basic Logic of Pathogen Nucleic Acid Detection

The core of pathogen nucleic acid detection lies in identifying nucleic acid sequences unique to microorganisms and amplifying the signal to a detectable level through specific amplification or hybridization. Compared with immunological methods, nucleic acid detection has certain advantages in the window period, pathogen typing, and low-load samples. Common detection targets include viral RNA, viral DNA, bacterial genomes, and fungal ribosomal RNA. Because the nucleic acid structures of different pathogens vary greatly, pretreatment strategies need to be adjusted accordingly.

Commonly Used Amplification Technology Routes

Currently, widely used amplification technologies include polymerase chain reaction, isothermal amplification, and digital PCR. Polymerase chain reaction achieves exponential amplification through cycles of denaturation, annealing, and extension, and is suitable for multiplex target detection. Isothermal amplification, such as loop-mediated isothermal amplification and recombinase polymerase amplification, has relatively relaxed requirements for instrument temperature control, making it convenient for use in primary care or on-site testing scenarios. Digital PCR partitions the reaction system into a large number of micro-units, making it suitable for low-abundance targets or absolute quantification needs, but it has certain constraints in operational throughput and consumables.

Sample Collection and Pretreatment

Sample quality directly affects detection results. Nasopharyngeal swabs, oropharyngeal swabs, or sputum are commonly used for respiratory pathogens, whole blood or plasma is mostly used for bloodstream infection-related detection, and cerebrospinal fluid is required for central nervous system infections. The pretreatment steps include inactivation, lysis, nucleic acid extraction, and purification. Disruption of the viral particle envelope requires the selection of an appropriate lysis buffer. Gram-positive bacteria or fungi have thicker cell walls and may require additional enzymatic digestion or mechanical disruption steps. Residual inhibitors in the extracted product can affect subsequent amplification efficiency, so extraction efficiency and purity need to be evaluated simultaneously.

Amplification System and Quality Control

The amplification system generally includes primers, probes, polymerase, buffer, and necessary auxiliary components. Primer design needs to consider target conservation and specificity, avoiding the formation of stable dimers with non-target sequences. Hydrolysis probes or molecular beacons are commonly used as probes, and the selection of fluorescence channels needs to take instrument compatibility into account. Positive controls, negative controls, and internal standards should be set up for each batch of experiments. Internal standards are used to monitor whether inhibition exists in the extraction and amplification process. When quality control data are abnormal, report issuance should be suspended and reagents, instruments, or operational steps should be investigated.

Result Interpretation and Reporting Specifications

The shape of the amplification curve, Ct value, or quantitative results need to be interpreted in combination with threshold setting rules. Weakly positive samples should be rechecked to avoid misjudgment caused by contamination or nonspecific amplification. Report content generally includes the detection target, methodology, interpretation of results, and statement of limitations. When issuing reports, laboratories need to clarify the applicable scope of the detection method. A single negative result cannot be equated with ruling out infection, and a comprehensive judgment should be made in combination with clinical manifestations, epidemiological history, and other examinations.

Technology Selection and Common Misconceptions

When selecting pathogen nucleic acid detection products, laboratories should pay attention to the analytical sensitivity, specificity, precision of the kit, and adaptability to different instrument platforms. Parameters such as the limit of detection and linear range in common specifications only represent reagent performance, not clinical diagnostic efficacy. During operation, nucleic acid aerosol contamination, sample cross-contamination, and repeated freezing and thawing of reagents should be avoided. Daily maintenance of pipettes, biosafety cabinets, and thermal cyclers, along with regular environmental monitoring, is the foundation for maintaining the stability of the detection system.